查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
藥事申請 (RA) 外包服務的全球市場 (2022～2030年):成長、未來展望、競爭分析
市場調查報告書
商品編碼
1162483

藥事申請 (RA) 外包服務的全球市場 (2022～2030年):成長、未來展望、競爭分析

Regulatory Affairs Outsourcing Services Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

生命科學產業的主要課題，是來自法規當局的壓力和副作用相關訴訟增加，人口動態急劇的變化，產品平台的乾涸，非專利處方藥廠商的競爭加劇等。

有關醫藥品的開發、核準的成本新增加，由於在法規方面的責任和義務增加，企業採用藥事申請 (RA) 業務的外包服務。

本報告提供全球藥事申請 (RA) 外包服務的市場調查，市場概要，市場成長的各種影響因素分析，市場規模的變化、預測，各種區分、各地區/主要國家的明細，主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 藥事申請 (RA) 外包服務市場:事業預測、市場動態

  • 世界市場規模:2020年～2030年
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素、阻礙因素的影響分析
  • Seesaw分析
  • 波特的五力分析
  • PESTEL分析

第4章 藥事申請 (RA) 外包服務市場:各類型

  • 市場概要
  • 成長、收益分析
  • 市場分類
    • 照明、出版
    • 藥事諮詢
    • 臨床試驗、產品登記
    • 法定代理人
    • 其他的服務

第5章 北美的藥事申請 (RA) 外包服務市場

  • 市場概要
  • 藥事申請 (RA) 外包服務市場:各類型
  • 藥事申請 (RA) 外包服務市場:各地區

第6章 英國及EU的藥事申請 (RA) 外包服務市場

  • 市場概要
  • 藥事申請 (RA) 外包服務市場:各類型
  • 藥事申請 (RA) 外包服務市場:各地區

第7章 亞太地區的藥事申請 (RA) 外包服務市場

  • 市場概要
  • 藥事申請 (RA) 外包服務市場:各類型
  • 藥事申請 (RA) 外包服務市場:各地區

第8章 南美的藥事申請 (RA) 外包服務市場

  • 市場概要
  • 藥事申請 (RA) 外包服務市場:各類型
  • 藥事申請 (RA) 外包服務市場:各地區

第9章 中東、非洲的藥事申請 (RA) 外包服務市場

  • 市場概要
  • 藥事申請 (RA) 外包服務市場:各類型
  • 藥事申請 (RA) 外包服務市場:各地區

第10章 企業簡介

  • ICON plc
  • Quintiles Transnational Corporation
  • PAREXEL International Corporation
  • Covance, Inc.
  • Clinilabs, Inc.
  • Charles River Laboratories International, Inc.
  • Accell Clinical Research, LLC
  • Criterium, Inc.
  • Medpace, Inc.
  • Promedica International
  • WuXi App Tec
  • Genpact Ltd
  • PRA Health Sciences, Inc.
  • Pharmaceutical Product Development(PPD), LLC
Product Code: 138653-08-22

Industry Outlook

Growing regulatory pressure and challenge of litigations over adverse or side effects, rapidly changing demographic patterns, drying product pipelines and consistent growth in competition from generic manufacturers are some of the prime challenges faced in the life sciences business. Further growth in cost of drug development, approvals and growing responsibilities and obligations on the regulatory front have driven organizations to adopt outsourcing services for regulatory operations. These activities are proven to result in improved cost efficiencies, while manufacturers becoming more focused on their core competencies. Diversification of several ancillary activities allows organizations to focus in improving core business while the third party vendors deliver optimal services. Some major advantages derived from regulatory affairs outsourcing are increased speed of market approvals, effective maintenance of product success in new and emerging markets, and swift and convenient extension of brand indications and formulations. Regulatory affairs outsourcing is also of high advantage for mid and small size companies that lack expertize in certain departments. This also reduced the work-load on the employees and management while also ensure appropriate timely and prompt regulatory submissions.

Regulatory writing and publishing to be the major revenue generator, while clinical trial and product registration services to pick pace within the forecast period

Among the major regulatory affairs outsourcing services, regulatory writing and publishing occupy the largest revenue share in the global market. As the global market is condensing, there is a prominent visibility of distinct regulatory scenarios in different regions. Companies domiciled in Europe and North America often face challenge in terms of regulatory submissions to emerging markets of Asia Pacific, and Middle East & Africa. The regulations worldwide are also changing rapidly due to growing interest to ensure rapid commercialization of products with assured safety profile. Therefore, it has become imperative for manufacturers to provide timely data updating of regulatory submissions and literature. Furthermore, it is anticipated that the market for clinical trials and product registration services shall be witnessing rapid growth during the forecast period. Impending patent expiries, and increasing focus of drug manufacturers on delivering drugs for rare diseases have prompted emergence of pipeline for specialty drugs. With growth in the number of such drug candidates, the demand for clinical trial and product registration services shall be growing in the years to come.

Asia Pacific to become the global outsourcing hub

Manufacturers of several blockbuster drugs are domiciled in Europe and North America, where the patents for such drugs are rapidly expiring. In order to enable extension to the product life cycle, several of such manufacturers have increased their efforts in introducing their drugs and medical devices to the emerging markets of Asia Pacific. Companies are harnessing the potential of the emerging economies as an introduction opportunity for their businesses and products in the developed markets. CDMO and regulatory outsourcing activities are being increasingly set up in emerging economies due to cheap labor, improving skills and low service costs.

This report also includes company profiles section that gives insights on the company overview, product portfolio, financial information and key developments of major market players. The major players profiled in this report include ICON plc, Quintiles Transnational Corporation, PAREXEL International Corporation, Covance, Inc., Clinilabs, Inc., Charles River Laboratories International, Inc., Accell Clinical Research, LLC, Criterium, Inc., Medpace, Inc., Promedica International, WuXi App Tec, Genpact Ltd, PRA Health Sciences, Inc. and Pharmaceutical Product Development (PPD), LLC.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Regulatory Affairs Outsourcing Services market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Regulatory Affairs Outsourcing Services market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Regulatory Writing & Publishing
  • Regulatory Consulting
  • Clinical Trial & Product Registration
  • Legal Representation
  • Other Services

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Regulatory Affairs Outsourcing Services market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Regulatory Affairs Outsourcing Services market?
  • Which is the largest regional market for Regulatory Affairs Outsourcing Services market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Regulatory Affairs Outsourcing Services market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Regulatory Affairs Outsourcing Services market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Regulatory Affairs Outsourcing Services Market
  • 2.2. Global Regulatory Affairs Outsourcing Services Market, By Type, 2021 (US$ Million)
  • 2.3. Global Regulatory Affairs Outsourcing Services Market, By Geography, 2021 (US$ Million)
  • 2.4. Impact of Covid 19
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Competitive Analysis
    • 2.6.1. Market Positioning of Key Regulatory Affairs Outsourcing Services Market Vendors
    • 2.6.2. Strategies Adopted by Regulatory Affairs Outsourcing Services Market Vendors
    • 2.6.3. Key Industry Strategies

3. Regulatory Affairs Outsourcing Services Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Regulatory Affairs Outsourcing Services Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Regulatory Affairs Outsourcing Services Market: By Type, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Regulatory Writing & Publishing
    • 4.3.2. Regulatory Consulting
    • 4.3.3. Clinical Trial & Product Registration
    • 4.3.4. Legal Representation
    • 4.3.5. Other Services

5. North America Regulatory Affairs Outsourcing Services Market, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Regulatory Affairs Outsourcing Services Market: By Type, 2020-2030, USD (Million)
  • 5.3.Regulatory Affairs Outsourcing Services Market: By Region, 2020-2030, USD (Million)
    • 5.3.1.North America
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
      • 5.3.1.3. Rest of North America

6. UK and European Union Regulatory Affairs Outsourcing Services Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Regulatory Affairs Outsourcing Services Market: By Type, 2020-2030, USD (Million)
  • 6.3.Regulatory Affairs Outsourcing Services Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.UK and European Union
      • 6.3.1.1. UK
      • 6.3.1.2. Germany
      • 6.3.1.3. Spain
      • 6.3.1.4. Italy
      • 6.3.1.5. France
      • 6.3.1.6. Rest of Europe

7. Asia Pacific Regulatory Affairs Outsourcing Services Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Regulatory Affairs Outsourcing Services Market: By Type, 2020-2030, USD (Million)
  • 7.3.Regulatory Affairs Outsourcing Services Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.Asia Pacific
      • 7.3.1.1. China
      • 7.3.1.2. Japan
      • 7.3.1.3. India
      • 7.3.1.4. Australia
      • 7.3.1.5. South Korea
      • 7.3.1.6. Rest of Asia Pacific

8. Latin America Regulatory Affairs Outsourcing Services Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Regulatory Affairs Outsourcing Services Market: By Type, 2020-2030, USD (Million)
  • 8.3.Regulatory Affairs Outsourcing Services Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Latin America
      • 8.3.1.1. Brazil
      • 8.3.1.2. Mexico
      • 8.3.1.3. Rest of Latin America

9. Middle East and Africa Regulatory Affairs Outsourcing Services Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Regulatory Affairs Outsourcing Services Market: By Type, 2020-2030, USD (Million)
  • 9.3.Regulatory Affairs Outsourcing Services Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Middle East and Africa
      • 9.3.1.1. GCC
      • 9.3.1.2. Africa
      • 9.3.1.3. Rest of Middle East and Africa

10. Company Profile

  • 10.1. ICON plc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Initiatives
  • 10.2. Quintiles Transnational Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Initiatives
  • 10.3. PAREXEL International Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Initiatives
  • 10.4. Covance, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Initiatives
  • 10.5. Clinilabs, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Initiatives
  • 10.6. Charles River Laboratories International, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Initiatives
  • 10.7. Accell Clinical Research, LLC
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Initiatives
  • 10.8. Criterium, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Initiatives
  • 10.9. Medpace, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Initiatives
  • 10.10. Promedica International
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Portfolio
    • 10.10.4. Strategic Initiatives
  • 10.11. WuXi App Tec
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Portfolio
    • 10.11.4. Strategic Initiatives
  • 10.12. Genpact Ltd
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Portfolio
    • 10.12.4. Strategic Initiatives
  • 10.13. PRA Health Sciences, Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Portfolio
    • 10.13.4. Strategic Initiatives
  • 10.14. Pharmaceutical Product Development (PPD), LLC
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Portfolio
    • 10.14.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Regulatory Affairs Outsourcing Services Market By Type, 2020-2030, USD (Million)
  • TABLE 2 North America Regulatory Affairs Outsourcing Services Market By Type, 2020-2030, USD (Million)
  • TABLE 3 UK and European Union Regulatory Affairs Outsourcing Services Market By Type, 2020-2030, USD (Million)
  • TABLE 4 Asia Pacific Regulatory Affairs Outsourcing Services Market By Type, 2020-2030, USD (Million)
  • TABLE 5 Latin America Regulatory Affairs Outsourcing Services Market By Type, 2020-2030, USD (Million)
  • TABLE 6 Middle East and Africa Regulatory Affairs Outsourcing Services Market By Type, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Regulatory Affairs Outsourcing Services Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Regulatory Affairs Outsourcing Services Market: Quality Assurance
  • FIG. 5 Global Regulatory Affairs Outsourcing Services Market, By Type, 2021
  • FIG. 6 Global Regulatory Affairs Outsourcing Services Market, By Geography, 2021
  • FIG. 7 Global Regulatory Affairs Outsourcing Services Market, By Type, 2021 Vs 2030, %
  • FIG. 8 U.S. Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 9 Canada Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 10 Rest of North America Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 11 UK Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 12 Germany Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 13 Spain Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 14 Italy Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 15 France Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of Europe Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 17 China Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 18 Japan Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 19 India Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 20 Australia Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 21 South Korea Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Asia Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 23 Brazil Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 24 Mexico Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Latin America Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 26 GCC Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 27 Africa Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Middle East and Africa Regulatory Affairs Outsourcing Services Market (US$ Million), 2020 - 2030